{
    "clinical_study": {
        "@rank": "13103", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This observational study will evaluate the use in clinical practice and the efficacy of\n      Avastin (bevacizumab) in patients with metastatic colorectal cancer who have not received\n      prior chemotherapy treatment in the metastatic setting. Patients for whom the treating\n      physician has decided to initiate therapy with Avastin will be followed for 10 months."
        }, 
        "brief_title": "An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/= 18 years of age\n\n          -  Histologically confirmed metastatic colorectal cancer without prior chemotherapy in\n             the metastatic setting\n\n        Exclusion Criteria:\n\n          -  Contraindications for Avastin according to the locally approved package insert\n             (version 7 April 2006)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with metastatic colorectal cancer without prior chemotherapy in the metastatic\n        setting"
            }
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01674907", 
            "org_study_id": "ML22399"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "zip": "7500"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "George", 
                        "country": "South Africa", 
                        "zip": "6529"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Elizabeth", 
                        "country": "South Africa", 
                        "zip": "6045"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pretoria", 
                        "country": "South Africa", 
                        "zip": "0001"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vereeniging", 
                        "country": "South Africa", 
                        "zip": "1939"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "South Africa"
        }, 
        "number_of_groups": "1", 
        "official_title": "Non-interventional Study of Avastin in 1st Line Metastatic Colorectal Cancer", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Africa: Medicines Control Council of South Africa"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Dosage/schedule of 1st-line Avastin", 
                "safety_issue": "No", 
                "time_frame": "approximately 3 years"
            }, 
            {
                "measure": "Duration of treatment", 
                "safety_issue": "No", 
                "time_frame": "approximately 3 years"
            }, 
            {
                "measure": "Chemotherapy regimens used in clinical practice", 
                "safety_issue": "No", 
                "time_frame": "approximately 3 years"
            }, 
            {
                "measure": "Clinical/demographic patient characteristics at baseline", 
                "safety_issue": "No", 
                "time_frame": "approximately 3 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01674907"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Progression-free survival", 
                "safety_issue": "No", 
                "time_frame": "approximately 3 years"
            }, 
            {
                "measure": "Relationship between termination of Avastin treatment and time point of progression", 
                "safety_issue": "No", 
                "time_frame": "approximately 3 years"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}